Stocks
Intellia Therapeutics (NTLA) OCF US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| OCF, bln rub | ? | -225.0 | -333.3 | -394.1 | -348.9 | -348.9 | -363.2 | ||
| Changes by years, y/y, % | +351% | +48% | +18% | -11% | 0% | +47.5% | |||
Intellia Therapeutics. OCF, bln rub
Intellia Therapeutics. OCF, changes, %
Intellia Therapeutics. OCF, sum by quarters, bln rub
Intellia Therapeutics (NTLA) OCF US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| OCF, bln rub | ? | -148.9 | -99.6 | -76.9 | -69.3 | -117.3 | -363.2 | |
| Changes by years, y/y, % | +23% | +71% | -9% | -19% | -21% | |||
| Changes by quarters, q/q, % | +75% | -33% | -23% | -10% | +69% | |||
